期刊文献+

COX-2在Barrett食管中的表达及意义 被引量:2

Expression of COX-2 in Barrett Esophagus and Its Significance
下载PDF
导出
摘要 目的:探讨环氧合酶-2(COX-2)在Barrett食管(BE)中的表达及意义。方法:用免疫组织化学二步法染色检测COX-2在BE、慢性食管炎及正常食管黏膜中的表达。结果:免疫组织化学染色显示COX-2主要在表层上皮细胞及化生的腺上皮细胞胞浆中表达,COX-2在BE和慢性食管炎中的表达较正常食管黏膜显著增高(P<0.005),而在前两组组织中的差异无统计学意义(P>0.05)。结论:COX-2可能参与慢性食管炎和BE的发生发展过程,并有可能促进BE向食管腺癌发展。 Objective: To investigate the expression of cyclooxygenase-2(COX-2) in Barrett esophagus(BE) and its significance.Methods: Expression of COX-2 was determined with two-step immunohistochemical staining in cases of chronic esophagitis,normal esophagus mucosa and BE which was definitely diagnosed by upper endoscopy and pathologic biopsy,and the data were analyzed statistically.Results: COX-2 protein was mainly expressed in cytoplasm of the surface epithelium and metaplasia glandular epithelium.The expression of COX-2 in BE and chronic esophagitis was significantly higher than that in normal esophageal mucosa(P〈0.005),while the difference of COX-2 protein expression between BE and chronic esophagitis was not statistically significant(P〉0.05).Conclusion: The intensified expression of COX-2 in BE and chronic esophagitis demonstrates that COX-2 might participate the development of chronic esophagitis,and further progress the development of BE,and stimulate BE turn into esophageal adenocarcinoma.
出处 《贵阳医学院学报》 CAS 2009年第2期170-172,共3页 Journal of Guiyang Medical College
关键词 氧合酶类 BARRETT食管 食管炎 oxygenases barrett esophagus esophagitis
  • 相关文献

参考文献14

  • 1Gallo O, Franchi A, Magnelli L, et al. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis[J].Neoplasia, 2001 ( 1 ) : 53 -61.
  • 2Wilson KT, Fu S, Ramanujam KS. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett' s esophagus and associated adenocarcinomas [ J ]. Cancer Res, 1998 (58) : 2929 - 2934.
  • 3Morita I. Distinct functions of COX-1 and COX-2 [ J]. Prostaglandins Other Lipid Mediat, 2002(68 -69) : 165 - 175.
  • 4Oyama Katsunobu, Fujimura Takashi, Ninomiya, Itasu, et al. A COX-2 inhibitor prevents the esophageal inflammation-metaplasia-adenocarcinoma sequence in rats [ J ]. Carcinogenesis, 2005 (3) : 565 - 570.
  • 5徐选福.环氧化酶在肿瘤发生和发展中的调节作用[J].国外医学(消化系疾病分册),2000,20(4):239-243. 被引量:8
  • 6Shirvani V N, Ouatu-Lascar R, Kaur B S, et al. Cyclooxygenterology-2 expression in Barretts esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure[J]. Gastroenterology, 2000 (3) : 487 - 496.
  • 7Vivian NS, Rodica OL, Baljeet K, et al. Cyclooxygenase- 2 expression in Barretts esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure [ J ]. Gastroenterology, 2001 ( 118 ) : 487 -496.
  • 8邹多武.抑酸治疗对Barrett食管的临床意义[J].现代消化及介入诊疗,2006,11(1):32-34. 被引量:2
  • 9Balkwill F, Mantovani A, Inflammation and cancer back to Virchow[ J ]. Lancet, 2001 (357) : 539 - 545.
  • 10Coussens LM, Werb Z. Inflammatory cells and cancer: think different[J]. J Exp Med, 2001 (193) : F23 - F26.

二级参考文献16

  • 1[1]Spechler S J,Goyal RK.The columnar-lined esophagus,intestinal metaplasia,and Norman Barrett.Gastroenterology 1996;110:614-621.
  • 2[2]Shaheen NJ,Crosby MA,Bozymski EM,et al.Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gatroenterology 2000;119:333-338.
  • 3[3]Watson DI,Jamieson GG.Antireflux surgery in the laparoscopic era.Br J Surg 1998;85:1173-1184.
  • 4[4]Gurski RR,Peters JH,Hagen JA,et al.Barrett's esophagus can and does regress after antireflux surgery:a study of prevalence and predictive features.J Am Coll Surg 2003;196:706-712.
  • 5[5]Peghini PL,Katz PO,Bracy NA,et al.Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors.Am J Gastroenterol 1998;93:763-767.
  • 6[6]Menges M,Muller M,Zeitz M.Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis,and effect of proton pump inhibitor therapy.Am J Gastroenterol 2001;96:331-337.
  • 7[7]Williams MP,Sercombe J,Hamilton MI,et al.A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects.Aliment Pharmacol Ther1998;12:1079-1089.
  • 8[8]Scott LJ,Dunn CJ,Mallarkey G,et al.Esomeprazole:a review of its use in the management of acid-related disorders in the US.Drugs2002;62:1091-1118.
  • 9[9]Orlando RC.Mechanisms of epithelial injury and inflammation in gastrointestinal diseases.Rev Gastroenterol Disord 2002;2(Suppl2):S2-8.
  • 10[10]Souza RF,Shewmake K,Terada LS,et al.Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus.Gastroenterology 2002;122:299-307.

共引文献8

同被引文献22

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部